18F-FDG and 11C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis

Clinical Nuclear Medicine

Volumn 37, Issue 4, 2012, Pages 400-402

  Morooka, Miyako ^a   Kubota, Kazuo ^a   Minamimoto, Ryogo ^a   Furuhata, Mariko ^b   Abe, Tadashi ^b   Ito, Kimiteru ^c   Okasaki, Momoko ^a   Ishii, Kenji ^d   Ishiwata, Kiichi ^d  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

encephalitis; FDG; methionine; NMDA; PET

Indexed keywords

11C METHIONINE; AUTOANTIBODY; FLUORODEOXYGLUCOSE F 18; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR EPSILON 2 AUTOANTIBODY; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON 11 METHIONINE; CARBON-11 METHIONINE; DIAGNOSTIC AGENT; METHIONINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

AGED; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY TITER; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSCIOUSNESS LEVEL; EGO DEVELOPMENT; HUMAN; MALE; PARANEOPLASTIC NEUROPATHY; ENCEPHALITIS; IMMUNOLOGY; METABOLISM; SCINTISCANNING;

AGED; AUTOANTIBODIES; ENCEPHALITIS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; METHIONINE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84863411234     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182443c92     Document Type: Article

References (11)

1. Dalmau J, Rosenfeld M. Update on paraneoplastic neurologic disorders. Community Oncol. 2010;7:219-224.
2. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504-511. (Pubitemid 351653374)
3. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10:131-137.
4. Novillo-Lopez ME, Rossi JE, Palmau J, et al. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology. 2008;70:728-729.
5. Pillai SC, Gill D, Webster R, et al. Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol. 2010;43:217-220.
6. Maeder IM, Prior JO, Irani SR, et al. FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NMDA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry. 2011;82:235-236.
7. Mohr BD, Minoshima S. F-18 fluorodeoxyglucose PET/CT findings in a case of anti-NMDA receptor encephalitis. Clin Nucl Med. 2010;35:461-463.
8. Ochi H, Yamada T, Hara H, et al. A case of progressive multifocal leukoencephalopathy with methionine uptake demonstrated by PET [in Japanese]. Clin Neurol. 1996;36:858-863. (Pubitemid 26391121)
9. Rokutanda T, Inatomi Y, Yonehara T, et al. A case of glioglastoma misdiagnosed initially due to positive finding of anti-glutamate receptor antibody [in Japanese]. Clin Neurol. 2008;48:497-500.
10. Maeda Y, Oguni H, Saitou Y, et al. Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings. Epilepsia. 2003;44: 1118-1121. (Pubitemid 36959321)
11. Salber D, Stoffels G, Pauleit D, et al. Differential uptake of o-(2-18Ffluoroethyl)- L-tyrosine, L-3H-mthionine, and 3H-deoxyglucose in brain abscesses. J Nucl Med. 2007;48:2056-2062. (Pubitemid 350232317)